116 40.Resveratrol in Health and Disease Aziz M, Afaq F, and Ahmad N, Prevention of ultraviolet B radiation damage by resveratrol in mouse skin is mediated via modulation in survivin, Photochemistry and Photobiology 81, 25�1, 2005. Jazirehi AR and Bonavida B, Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis, Molecular Cancer Therapeutics 3, 71�4, 2004. She QB, Huang C, Zhang Y, and Dong Z, Involvement of c-jun NH(2)terminal kinases in resveratrol-induced activation of p53 and apoptosis, Molecular Carcinogenesis 33, 244�50, 2002. Pozo-Guisado E, Lorenzo-Benayas MJ, and Fernandez-Salguero PM, Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation, International Journal of Cancer 109, 167�73, 2004. Kaneuchi M, Sasaki M, Tanaka Y, Yamamoto R, Sakuragi N, and Dahiya R, Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF, International Journal of Oncology 23, 1167�172, 2003. Yu R, Hebbar, V, Kim DW, Mandlekar S, Pezzuto, JM, and Kong, A-NT, Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways, Molecular Pharmacology 60, 217�24, 2001. Huang C, Ma W, Goranson A, and Dong Z, Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway, Carcinogenesis 20, 237�42, 1999. She Q-B, Bode AM, Ma W-Y, Chen N-Y, and Dong Z, Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular signal-regulated protein kinases and p38 kinase, Cancer Research 61, 1604�610, 2001. Shih A, Davis FB, Lin H-Y, and Davis PJ, Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism, Journal of Clinical Endocrinology and Metabolism 87, 1223�232, 2002. Miloso M, Bertelli AA, Nicolini G, and Tredici G, Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells, Neuroscience Letters 264, 141�44, 1999. Haider UGB, Sorescu D, Griendling KK, Vollmar AM, and Dirsch VM, Resveratrol suppresses angiotensin II-induced AKT/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells, Molecular Pharmacology 62, 772�77, 2002. Liu Y and Liu G, Isorhapontigenin and resveratrol suppress oxLDL-induced proliferation and activation of ERK1/2 mitogen-activated protein kinases of bovine aortic smooth muscle cells, Biochemical Pharmacology 67, 777�85, 2004. El-Mowafy AM and White RE, Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin1 stimulatory effects, FEBS Letters 451, 63�7, 1999. Slater SJ, Seiz JL, Cook AC, Stagliano BA, and Buzas CJ, Inhibition of protein kinase C by resveratrol, Biochimica et Biophysica Acta 1637, 59�9, 2003. Yuan SY, Protein kinase signaling in the modulation of microvascular permeability, Vascular Pharmacology 39, 213�23, 2002.41.42.43.44.45.46.47.48.49.50.51.52.53. 54.
